Jamie Bourque, MD, spoke to Cardiovascular Business about the growing number of ways FDG-PET scans are being used in cardiology. This includes evaluating inflammation, tracking EP device infections and much more. 

David Hur, MD, director of structural heart disease/interventional imaging at the VA Connecticut Healthcare System, and an assistant professor of medicine at Yale, explains the technical challenges encountered in cardiac computed tomography (CT) and how to overcome them.

Robert Hendel, MD, discussed everything from declining reimbursements in cardiology to prior authorization policies in an exclusive new interview. 

The new radiotracer flurpiridaz is poised to make a major impact on nuclear cardiology. Timothy Bateman, MD, co-director of the cardiovascular radiologic imaging program at Saint Luke's Mid America Heart Institute, shared details on the tracer in a new interview. 

Mark Rabbat, MD, discusses the Society of Cardiovascular Computed Tomography's efforts to make an impact by lobbying in Washington. 

Researchers noted that patients appeared to have myocarditis at first, but a closer examination revealed it was something else entirely. 

Cardiologist Martha Gulati, MD, lead author of the 2021 chest pain guidelines, explained how the document may have contributed to the rise of cardiac CT. "These guidelines have made it harder for people to push back and say you don't need this test," she said. 

ASNC President President Mouaz Al-Mallah, MD, said nuclear cardiology needs to upgrade old imaging systems and embrace new technology to deliver better value for patients.